The relevance of c-myc to the physiology of the human ovary

Gynecological Endocrinology

Volumn 11, Issue 1, 1997, Pages 5-10

  Putowski, L T ^a   Skrzypczak, M ^a   Zielewicz, J ^a   Kaminski, K ^a   Jakowicki, J A ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Apoptosis; Granulosa cell; In situ hybridization; Ovary

Indexed keywords

DNA FRAGMENT; MESSENGER RNA;

ADULT; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CORPUS LUTEUM; FEMALE; GENE EXPRESSION; GENE LOCATION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; NORMAL HUMAN; ONCOGENE C MYC; OVARY; OVARY FOLLICLE ATRESIA; OVARY FOLLICLE DEVELOPMENT; POSTMENOPAUSE; PRIORITY JOURNAL;

EID: 0031049186     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.3109/09513599709152309     Document Type: Article

References (26)

1. Blackwood, E. M. and Eisenman, R. N. (1991). Max: a helix-loop-helix zipper protein that forms a sequence specific DNA-binding complex with Myc. Science, 251, 1211-17
2. Eilers, J. K., Schirm, S. and Bishop, J. M. (1991). The Myc protein activates transcription of the alpha-prothymosin gene. EMBO J., 10, 133-41
3. Buttyan, R., Zakeri, Z., Lockshin, R. and Wolgemuth, D. (1988). Cascade induction of c-fos, c-myc and heat shock 70K transcripts during regression of the rat ventral prostate gland. Mol. Endocrinol., 2, 650-7
4. Kyprianou, N., English, H. F., Davidson, N. E. and Isaacs, J. T. (1991). Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation. Cancer Res., 51, 162-6
5. Quarmby, V., Beekman, W., Wilson, E. and French, F. (1987). Androgen regulation of c-myc messenger ribonucleic acid levels in rat ventral prostate. Mol. Endocrinol., 1, 865-74
6. Goyette, M., Petropoulos, C. J., Shank, P. R. and Fausto, N. (1984). Regulated transcription of c-Ki-ras and c-myc during compensatory growth of rat liver. Mol. Cell. Biol., 4, 1493-8
7. Makino, R., Hayashi, K. and Sugimura, T. (1984). C-myc transcript is induced in rat liver at a very early stage of regeneration or by cycloheximide treatment. Nature (London), 310, 697-8
8. Slamon, D. J., deKernion, J. B., Verma, I. M. and Cline, M. J. (1984). Expression of cellular proto-oncogenes in human malignancies. Science, 224, 256-62
9. Yasue, H., Takeda, A. and Ishibashi, M. (1987). Amplification of the c-myc gene and the elevation of its transcript in human ovarian cell lines. Cell Struct. Funct., 12, 121-5
10. Delidow, B. C., Lynch, J. P., White, B. A. and Peluso, J. J. (1992). Regulation of proto-oncogene expression and deoxyribonucleic acid synthesis in granulosa cells of perfused immature rat ovaries. Biol. Reprod., 47, 428-35
11. Fraser, H. M., Lunn, S. F., Cowen, G. M. and Illingworth, P. J. (1995). Induced luteal regression in the primate: evidence for apoptosis and changes in c-myc protein. J. Endocrinol., 147, 131-7
12. Delidow, B.C., White, B. A. and Peluso, J. J. (1990). Gonadotropin induction of c-fos and c-myc expression and deoxyribonucleic acid synthesis in rat granulosa cells. Endocrinology, 126, 2302-6
13. Clement, P. B. (1987). Histology of the ovary. Am. J. Surg. Pathol., 11, 277-303
14. Chikazawa, K., Araki, S. and Tamada, T. (1986). Morphological and endocrinological studies on follicular development during the human menstrual cycle. J. Clin. Endocrinol. Metab., 62, 305-13
15. Gibson, A. W., Cheng, T. and Johnston, R. N. (1995). Apoptosis induced by c-mycoverexpression is dependent on growth conditions. Exp. Cell Res., 218, 351-8
16. 1. Nature (London), 328, 445-9
17. Yokoyama, K. and Imamoto, F. (1987). Transcriptional control of the endogenous MYC proto-oncogene by antisense RNA. Proc. Natl. Acad. Sci. USA, 84, 7363-7
18. Johnson, A. L., Li, Z. and Tilly, J. L. (1993). Expression of c-myc and bcl-2 mRNA during ovarian follicle development. Presented at the 26th Annual Meeting of the Society for the Study of Reproduction, Fort Collins, USA, August, p. 152, abstr.
19. Czerwiec, F. S., Melner, M. H. and Puett, D. (1989). Transiently elevated levels of c-fos and c-myc oncogene messenger ribonucleic acid in cultured murine Leydig tumor cells after addition of human chorionic gonadotropin. Mol. Endocrinol., 3, 105-9
20. Lin, T., Blaisdell, K., Barbour, K. W. and Thompson, E. A. (1988). Transient activation of c-myc proto-oncogene expression in Leydig cells by human chorionic gonadotropin. Biochem. Biophys. Res. Commun., 157, 121-6
21. Coughlin, S. R., Lee, W. M., Williams, P. W., Giels, G. M. and Williams, L. T. (1985). C-myc gene expression is stimulated by agents that activate protein kinase C and does not account for the mitogenic effect of PDGF. Cell, 43, 243-51
22. Shi, Y., Glynn, J. M., Guilbert, L. J., Cotter, T. G., Disonette, R. P. and Green, D. R. (1992). Role of c-myc in activation induced apoptotic cell death in T-cell hybridomas. Science, 257, 212-14
23. Hockenbery, D., Nunez, G., Milliman, C., Schreiber, R. D. and Krosmeyer, S. J. (1990). Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature (London), 348, 334-6
24. long messenger ribonucleic acid level. Endocrinology, 136, 232-41
25. Copolla, J. A. and Cole, M. D. (1986). Constitutive c-myc expression blocks mouse erythroleukemia cell differentiation but not commitment. Nature (London), 320, 760-3
26. Falcone, G., Tao, F. and Alema, S. (1985). Distinctive effect of the viral oncogenes myc, erb, fps and src on the differentiation programme of the quail myogenic cells. Proc. Natl. Acad. Sci. USA, 82, 426-30